Regulatory requirements for marketing fixed dose combinations
2010

Regulatory Requirements for Marketing Fixed Dose Combinations

publication

Author Information

Author(s): Jayasheel B. G. Bangaragiri

Conclusion

Fixed-dose combinations (FDCs) can improve patient compliance and treatment efficacy but require careful regulatory approval.

Supporting Evidence

  • FDCs can reduce pill burden and improve medication compliance.
  • FDCs may lower manufacturing costs compared to separate products.
  • Clinical trials may be required to prove the efficacy of FDCs.

Takeaway

This article talks about how combining medicines into one pill can help people take their medicine better and may work better for some diseases.

Limitations

The heterogeneity of therapeutic fields makes it difficult to create standard guidance for FDCs.

Digital Object Identifier (DOI)

10.4103/2229-3485.71768

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication